Hematoxylin binds to mutant calreticulin and disrupts its abnormal interaction with thrombopoietin receptor.

Blood
Ruochen JiaR Kralovics

Abstract

Somatic mutations of calreticulin (CALR) have been identified as a main disease driver of myeloproliferative neoplasms, suggesting that development of drugs targeting mutant CALR is of great significance. Site-directed mutagenesis in the N-glycan binding domain (GBD) abolishes the ability of mutant CALR to oncogenically activate the thrombopoietin receptor (MPL). We therefore hypothesized that a small molecule targeting the GBD might inhibit the oncogenicity of the mutant CALR. Using an in silico molecular docking study, we identified candidate binders to the GBD of CALR. Further experimental validation of the hits identified a group of catechols inducing a selective growth inhibitory effect on cells that depend on oncogenic CALR for survival and proliferation. Apoptosis-inducing effects by the compound were significantly higher in the CALR-mutated cells than in CALR wild-type cells. Additionally, knockout or C-terminal truncation of CALR eliminated drug hypersensitivity in CALR-mutated cells. We experimentally confirmed the direct binding of the selected compound to CALR, disruption of the mutant CALR-MPL interaction, inhibition of the JAK2-STAT5 pathway, and reduction at the intracellular level of mutant CALR upon drug treatm...Continue Reading

References

Sep 21, 2000·The Journal of Biological Chemistry·F ValleeP L Howell
Mar 15, 2001·Proceedings of the National Academy of Sciences of the United States of America·L EllgaardK Wüthrich
Oct 16, 2002·The Journal of Biological Chemistry·Lei GuoMarek Michalak
Mar 23, 2005·Lancet·E Joanna BaxterUNKNOWN Cancer Genome Project
Apr 29, 2005·The New England Journal of Medicine·Robert KralovicsRadek C Skoda
Sep 28, 2005·Cell Stress & Chaperones·Sten P Thomson, David B Williams
Oct 20, 2006·Biochemical and Biophysical Research Communications·Jayashree GopalakrishnapaiAvadhesha Surolia
Feb 3, 2007·The New England Journal of Medicine·Linda M ScottAnthony R Green
Oct 1, 2010·The Journal of Biological Chemistry·Guennadi KozlovKalle Gehring
Oct 9, 2013·The Journal of Biological Chemistry·Sanjeeva J WijeyesakereMalini Raghavan
Oct 26, 2013·Nature Protocols·F Ann RanFeng Zhang
Dec 12, 2013·The New England Journal of Medicine·Thorsten KlampflRobert Kralovics
Dec 12, 2013·The New England Journal of Medicine·J NangaliaA R Green
Aug 8, 2014·Nature Protocols·Rozbeh JafariDaniel Martinez Molina
Oct 11, 2014·Nucleic Acids Research·Eva K BrinkmanBas van Steensel
May 27, 2015·ACS Chemical Biology·Thomas MachleidtKeith V Wood

❮ Previous
Next ❯

Citations

Apr 9, 2021·Blood·Julia E Maxson
Jun 8, 2021·HemaSphere·Stefan N ConstantinescuNicolas Papadopoulos

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis